Biosolution Co.Ltd (086820) — Capital Reinvestment Ratio
Biosolution Co.Ltd (086820) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩17.41 Million) in capital expenditures (₩22.15 Million). See debt-free asset ratio of Biosolution Co.Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biosolution Co.Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks Biosolution Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. Check total reinvestment intensity of Biosolution Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biosolution Co.Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for Biosolution Co.Ltd from 2018 to 2023. For live market cap and broader valuation context, see 086820 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.54x | ₩2.16 Billion | ₩1.16 Billion | ▼ -93.3% |
| 2021 | 7.96x | ₩83.29 Million | ₩663.15 Million | ▲ +1054.8% |
| 2018 | 0.69x | ₩1.03 Billion | ₩707.50 Million | — |